Clinico –pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis

ConclusionsThis analysis suggests that treatment of systemic disease is the major factor influencing survival in patients with BCBM. Moreover, targeted therapy with anti –HER2 increased survival when added to systemic therapy explaining the highest median OS noted in the Triple Positive subgroup.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research